Sign In
Buy RIGL
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High?
10:56am, Wednesday, 28'th May 2025
The consensus price target hints at a 72% upside potential for Rigel (RIGL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revi
Rigel to Present at the Jefferies Global Healthcare Conference
08:05am, Wednesday, 28'th May 2025
SOUTH SAN FRANCISCO, Calif. , May 28, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today anno
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress
05:20pm, Thursday, 22'nd May 2025
Final data from the GAVRETO® (pralsetinib) Phase 1/2 ARROW study in RET fusion-positive NSCLC and other solid tumors Supportive data for REZLIDHIA® (olutasidenib) utilization in patients with m
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now
10:56am, Wednesday, 14'th May 2025
Rigel (RIGL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend
Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now?
10:45am, Tuesday, 13'th May 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Earnings Estimates Rising for Rigel (RIGL): Will It Gain?
01:20pm, Friday, 09'th May 2025
Rigel (RIGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet
11:02am, Thursday, 08'th May 2025
The mean of analysts' price targets for Rigel (RIGL) points to an 82.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum
06:16pm, Wednesday, 07'th May 2025
Rigel Pharmaceuticals, Inc. shows strong momentum, with a 68% YoY revenue increase, driven by TAVALISSE, GAVRETO, and REZLIDHIA, suggesting a shift to a durable growth stock. Q1 net income of $11.4M a
Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript
11:13pm, Tuesday, 06'th May 2025
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Ray Furey - Executive Vice President, General Counsel & Corporate Secretary. Rau
Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates
06:30pm, Tuesday, 06'th May 2025
Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to loss of $0.50 per share a year ago.
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update
04:01pm, Tuesday, 06'th May 2025
First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $43.6 million and contract revenues from collaborations of $9.8 million Generated $11.4 million of
Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
08:05am, Tuesday, 29'th Apr 2025
SOUTH SAN FRANCISCO, Calif. , April 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2025 financial results after market close
Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Thursday, 17'th Apr 2025
Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
09:25am, Thursday, 17'th Apr 2025
Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the Trump administration's healthcare policies.
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
03:31pm, Friday, 04'th Apr 2025
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
